Home
Resources
Follow portfolio news
...

Corpuls acquires one of its historical partners

Published on
24/7/2025
Amended on
23/3/2026
0
minute(s)
Odyssey 2021
Corpuls
German company Corpuls acquires Messmer, its partner for over 35 years. Present in 60 countries, Corpuls develops cutting-edge medical equipment for heart disease. Until now, Messmer has been responsible for sales, technical advice and maintenance of Corpuls devices for a large part of Germany. Its full integration will enable Corpuls, a company present in the Vintage FPCI Altaroc Odyssey 2021, to further strengthen its position and accelerate the deployment of its devices in the field.
By
Antoine Orsoni
Antoine Orsoni
Corpuls acquires one of its historical partners
This article has been automatically translated. Please excuse any inaccuracies or translation errors.
Dieser Artikel wurde automatisch übersetzt. Bitte entschuldigen Sie etwaige Ungenauigkeiten oder Übersetzungsfehler.
Questo articolo è stato tradotto automaticamente. Ci scusiamo per eventuali inesattezze o errori di traduzione.

By becoming fully integrated into Corpuls, Messmer moves from the role of distributor to that of integrated operational pillar. Corpuls takes over all the employees and retains the premises of its historical partner, thus ensuring total continuity for customers while gaining greater control over service quality and response times. This acquisition meets a crucial need. To continue innovating while remaining compliant, we need to shorten decision-making chains, streamline support processes and control the entire product life cycle. The fact that Messmer's two historical managers, Stefan Koch and Jörn Schmidt, have been appointed co-directors of Messmer's historic site shows that Corpuls wants to maintain its proximity to local customers and preserve the expertise acquired in the field.

By fully integrating Messmer, Corpuls also gains in responsiveness. Devices such as defibrillators and cardiac monitors can be delivered, serviced and repaired more quickly, reducing critical delays in the event of an emergency. For doctors and rescue teams, this means more reliable access to high-performance, well-monitored tools, without logistical disruptions or complications. It also means greater compliance with increasingly stringent European standards, thanks to full traceability of each device and enhanced conformity. Finally, the acquisition of Messmer is combined with that of Cosinuss, which has enabled Corpuls to deploy mobile cardiac monitoring devices.

Other episodes on this topic

Explore our content collections, which bring together different formats around a single subject/issue/theme.
No articles in this category yet.
No items found.
Europe
Healthcare
Welcome to Altaroc
To provide you with a tailored experience, we invite you to complete your profile.
Your profile
country of tax residence
Select
choosenCountry
Preferred language
Select
choosenLang
Your investor profile
Financial intermediary or Professional investor
Financial advisors, wealth management advisors, private bankers, or any other investment service providers.
Qualified Investor or Altaroc Investor
Experienced Investor or Altaroc Investor
Private investors who have already invested in Altaroc who have a minimum investment capacity of €100,000.
Private investors who have already invested in Altaroc who have a minimum investment capacity of €250,000.
Inexperienced investor
Individual investors with an investment capacity of less than €100,000.
Individual investors with an investment capacity of less than €250,000.
Institutional investor
Pension funds, retirement funds, asset management firms, and single-family offices.
Scroll down to accept General Terms and Conditions
The webpage you are trying to access is not available in your country.